Improving Hypertension Medication Adherence for Older Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-02

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

NCT06307574

Aging Mild Cognitive Impairment Hypertension

RECRUITING NA

Habitual Hypertension Medication Adherence in Arizona

NCT05672797

Medication Adherence Habits Hypertension

COMPLETED NA

Testing Feasibility of Medication Adherence Problem Solving for Hypertension

NCT05630521

Hypertension Adherence, Medication

COMPLETED NA

Medication Adherence in Hypertension Study

NCT00688350

Hypertension

COMPLETED NA

Improving Medication Adherence in Hypertensive Patients

NCT01826435

Hypertension

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging Medication Adherence Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be screened and assigned to one of two groups using a blood pressure technology system.

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

All primary and secondary outcomes completed at 3-months and 6-months are blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blood Pressure Technology System M

These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.

Group Type OTHER

Blood Pressure Technology System M

Intervention Type OTHER

Participants will be provided the blood pressure technology system M. The study staff will teach the participants how to use the system on their personal cell phones with instruction guides. Participants will be asked to use the system for 6-months.

Blood Pressure Technology System E

These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.

Group Type OTHER

Blood Pressure Technology System E

Intervention Type OTHER

Participants will be provided the blood pressure technology system E. The study staff will teach the participants how to use the system on their personal cell phones with instruction guides. Participants will be asked to use the system for 6-months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Pressure Technology System M

Participants will be provided the blood pressure technology system M. The study staff will teach the participants how to use the system on their personal cell phones with instruction guides. Participants will be asked to use the system for 6-months.

Intervention Type OTHER

Blood Pressure Technology System E

Participants will be provided the blood pressure technology system E. The study staff will teach the participants how to use the system on their personal cell phones with instruction guides. Participants will be asked to use the system for 6-months.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 65 years or older
* self-manage at least one hypertension medication
* able to read and speak English
* willing to participate in the study for six months
* currently have and use an Apple iPhone
* have hypertension medication adherence ≤ 90% in the last 2 weeks of the 4-week baseline monitoring period using an AARDEX MEMS® cap

Exclusion Criteria

* have inadequate visual acuity (worse than 20/50 corrected near vision on Snellen test)
* experience severe depression (\> 11 on Geriatric Depression Scale Short Form, GDS-15)
* are at risk for cognitive impairment (\< 23 on Montreal Cognitive Assessment, MoCA)
* been instructed by their healthcare provider to withhold their blood pressure medication

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No